Valuation: CEREP

Market Cap 82.22M 94.04M 75.84M 69.72M 132M 9.05B 134M 905M 355M 4.42B 353M 345M 15.24B P/E 2024 *
-
P/E 2025 -
Enterprise Value 61.18M 69.98M 56.44M 51.88M 98.3M 6.73B 99.99M 674M 264M 3.29B 263M 257M 11.34B EV / Sales 2024
2.02x
EV / Sales 2025 1.67x
Free-Float
4.22%
Yield 2024 *
-
Yield 2025 -
Manager TitleAgeSince
Chief Executive Officer - 11/04/2024
Director TitleAgeSince
Chairman - 11/08/2023
Director/Board Member - 23/05/2024
Director/Board Member - -
Change 5-day change 1-year change 3-year change Capi.($)
-0.17%+1.47%+3.16%+7.43% 50.35B
-0.21%-2.68%+388.43%+594.01% 39.32B
+0.34%+2.19%+32.08%-5.92% 34.69B
+1.51%+2.77%+15.03%+56.77% 34.08B
+1.68%-1.40%+4.23%+27.34% 26.63B
+0.25%-4.21% - - 16.49B
-0.38%+0.35%+70.72%+115.82% 15.31B
+0.43%+3.34%+14.96%+17.98% 13.8B
+0.97%+2.13%+16.09%-31.03% 12.87B
Average +0.50%-0.41%+68.09%+97.80% 27.06B
Weighted average by Cap. +0.44%-0.32%+82.22%+122.50%

Financials

2024 2025
Net sales 40.49M 46.31M 37.35M 34.33M 65.05M 4.46B 66.17M 446M 175M 2.18B 174M 170M 7.51B 41.1M 47.01M 37.91M 34.85M 66.04M 4.52B 67.16M 453M 178M 2.21B 177M 173M 7.62B
Net income 7.15M 8.18M 6.6M 6.07M 11.5M 787M 11.69M 78.79M 30.92M 385M 30.73M 30.06M 1.33B 4.78M 5.47M 4.41M 4.06M 7.68M 526M 7.82M 52.67M 20.67M 257M 20.54M 20.09M 887M
Net Debt -17.25M -19.73M -15.92M -14.63M -27.72M -1.9B -28.2M -190M -74.55M -928M -74.11M -72.48M -3.2B -21.03M -24.06M -19.4M -17.84M -33.8M -2.32B -34.38M -232M -90.9M -1.13B -90.35M -88.37M -3.9B
Logo CEREP
Eurofins Cerep specializes in the pre-clinical research of drugs for the pharmaceutical industry. Export accounts for 88.2% of net sales.
Employees
-